Developments in non-anticholinergic anti-ulcer agents.
D000779:Anesthetics, Local / Q000627:therapeutic use; D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D002351:Carrageenan / Q000627:therapeutic use; D003714:Denervation; D004195:Disease Models, Animal; D004285:Dogs; D005227:Fatty Acids / Q000627:therapeutic use; D005730:Ganglionic Blockers / Q000627:therapeutic use; D005750:Gastric Juice / Q000378:metabolism*; D006035:Glycyrrhiza / Q000187:drug effects; D006168:Guinea Pigs; D006863:Hydrogen-Ion Concentration; D010368:Pectins / Q000627:therapeutic use; D010434:Pepsin A; D010437:Peptic Ulcer / Q000188:drug therapy*; D010648:Phenylacetates / Q000627:therapeutic use; D010946:Plants, Medicinal; D011398:Promethazine / Q000627:therapeutic use; D011437:Propylamines / Q000627:therapeutic use; D011708:Pylorus / Q000601:surgery; D011725:Pyridines / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D051381:Rats; D013270:Stomach / Q000294:innervation; D013844:Thiazoles / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014945:Wound Healing / Q000187:drug effects
D000779:Anesthetics, Local; D000962:Antimalarials; D002257:Carbonic Anhydrase Inhibitors; D005227:Fatty Acids; D005730:Ganglionic Blockers; D010648:Phenylacetates; D011437:Propylamines; D011725:Pyridines; D000644:Quaternary Ammonium Compounds; D013844:Thiazoles; D014149:Tranquilizing Agents; D010368:Pectins; D002351:Carrageenan; D010434:Pepsin A; D011398:Promethazine